PwC’s recent Health Services Deals Outlook suggests 2024 could be a dynamic year for healthcare mergers and acquisitions (M&A), despite a 13% decline in deal volume. Factors contributing to this cautious optimism include available capital, strategic imperatives, creative approaches, lower valuation multiples, and an attractive, resilient healthcare sector. However, challenges such as regulatory scrutiny and rising operational costs may pose obstacles.
Y chromosome loss creates hidden cancer vulnerability in men
A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men’s body
